428 related articles for article (PubMed ID: 20515211)
1. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention.
Witkiewitz K; Bowen S
J Consult Clin Psychol; 2010 Jun; 78(3):362-374. PubMed ID: 20515211
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.
Bowen S; Witkiewitz K; Clifasefi SL; Grow J; Chawla N; Hsu SH; Carroll HA; Harrop E; Collins SE; Lustyk MK; Larimer ME
JAMA Psychiatry; 2014 May; 71(5):547-56. PubMed ID: 24647726
[TBL] [Abstract][Full Text] [Related]
3. Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial.
Davis JP; Berry D; Dumas TM; Ritter E; Smith DC; Menard C; Roberts BW
J Subst Abuse Treat; 2018 Aug; 91():37-48. PubMed ID: 29910013
[TBL] [Abstract][Full Text] [Related]
4. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
[TBL] [Abstract][Full Text] [Related]
5. Enactment of home practice following mindfulness-based relapse prevention and its association with substance-use outcomes.
Grow JC; Collins SE; Harrop EN; Marlatt GA
Addict Behav; 2015 Jan; 40():16-20. PubMed ID: 25218066
[TBL] [Abstract][Full Text] [Related]
6. Mindfulness-based relapse prevention for substance craving.
Witkiewitz K; Bowen S; Douglas H; Hsu SH
Addict Behav; 2013 Feb; 38(2):1563-1571. PubMed ID: 22534451
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mindfulness-based relapse prevention in a sample of veterans in a substance use disorder aftercare program: A randomized controlled trial.
Killeen TK; Baker NL; Davis LL; Bowen S; Brady KT
J Subst Use Addict Treat; 2023 Sep; 152():209116. PubMed ID: 37364669
[TBL] [Abstract][Full Text] [Related]
8. [Mindfulness-based-relapse prevention (MBRP): Evaluation of the impact of a group of Mindfulness Therapy in alcohol relapse prevention for alcohol use disorders].
Carpentier D; Romo L; Bouthillon-Heitzmann P; Limosin F
Encephale; 2015 Dec; 41(6):521-6. PubMed ID: 26159682
[TBL] [Abstract][Full Text] [Related]
9. Mindfulness practice moderates the relationship between craving and substance use in a clinical sample.
Enkema MC; Bowen S
Drug Alcohol Depend; 2017 Oct; 179():1-7. PubMed ID: 28734167
[TBL] [Abstract][Full Text] [Related]
10. Feasibility, acceptability and preliminary outcomes of a mindfulness-based relapse prevention program in a naturalistic setting among treatment-seeking patients with alcohol use disorder: a prospective observational study.
von Hammerstein C; Khazaal Y; Dupuis M; Aubin HJ; Benyamina A; Luquiens A; Romo L
BMJ Open; 2019 Jun; 9(5):e026839. PubMed ID: 31154307
[TBL] [Abstract][Full Text] [Related]
11. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
Witkiewitz K; Lustyk MKB; Bowen S
Psychol Addict Behav; 2013 Jun; 27(2):351-365. PubMed ID: 22775773
[TBL] [Abstract][Full Text] [Related]
12. Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.
Roos CR; Bowen S; Witkiewitz K
J Consult Clin Psychol; 2017 Nov; 85(11):1041-1051. PubMed ID: 29083220
[TBL] [Abstract][Full Text] [Related]
13. Mindfulness-Based Relapse Prevention in a Jail Drug Treatment Program.
Lyons T; Womack VY; Cantrell WD; Kenemore T
Subst Use Misuse; 2019; 54(1):57-64. PubMed ID: 30409061
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial.
Brady KT; Killeen T; Baker NL
Contemp Clin Trials; 2021 Jun; 105():106393. PubMed ID: 33857680
[TBL] [Abstract][Full Text] [Related]
15. Race/ethnicity and racial group composition moderate the effectiveness of mindfulness-based relapse prevention for substance use disorder.
Greenfield BL; Roos C; Hagler KJ; Stein E; Bowen S; Witkiewitz KA
Addict Behav; 2018 Jun; 81():96-103. PubMed ID: 29454179
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Mindfulness-Based Relapse Prevention Program as an Adjunct to the Standard Treatment for Smoking: A Pragmatic Design Pilot Study.
Weiss de Souza IC; Kozasa EH; Bowen S; Richter KP; Sartes LMA; Colugnati FAB; Noto AR
Nicotine Tob Res; 2020 Aug; 22(9):1605-1613. PubMed ID: 32222767
[TBL] [Abstract][Full Text] [Related]
17. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.
Bowen S; Chawla N; Collins SE; Witkiewitz K; Hsu S; Grow J; Clifasefi S; Garner M; Douglass A; Larimer ME; Marlatt A
Subst Abus; 2009; 30(4):295-305. PubMed ID: 19904665
[TBL] [Abstract][Full Text] [Related]
18. Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders.
Zinzow H; Shi L; Rennert L; Chen L; Lopes S; Zhang L; Jones K; Jindal M; Stam C; Mclain M
Contemp Clin Trials; 2020 Dec; 99():106182. PubMed ID: 33080378
[TBL] [Abstract][Full Text] [Related]
19. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial.
Somohano VC; Bowen S
J Integr Complement Med; 2022 Sep; 28(9):729-738. PubMed ID: 35648046
[No Abstract] [Full Text] [Related]
20. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.
Zgierska AE; Burzinski CA; Mundt MP; McClintock AS; Cox J; Coe CL; Miller MM; Fleming MF
J Subst Abuse Treat; 2019 May; 100():8-17. PubMed ID: 30898331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
